Abstract
HIV vaccine development has been hampered by the inability of conventional immunogens to elicit antibodies capable of neutralizing primary isolates of the virus. Recent studies using 'fusion-competent' immunogens that capture transitional intermediate structures of the functioning envelope protein suggest that this goal may now be achievable. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
| Original language | English |
|---|---|
| Pages (from-to) | 213-221 |
| Number of pages | 9 |
| Journal | Microbes and Infection |
| Volume | 2 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2000 |
Keywords
- Antibodies
- Envelope protein
- Fusion
- Human immunodeficiency virus
- Vaccines
- Virus neutralization